Vitalhub (TSE:VHI) PT Set at C$15.00 by Canaccord Genuity Group

Vitalhub (TSE:VHI) has been assigned a C$15.00 price target by investment analysts at Canaccord Genuity Group in a research note issued on Friday,BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price target suggests a potential upside of 70.26% from the company’s current price.

Separately, National Bank Financial reduced their target price on shares of Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating on the stock in a report on Wednesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of C$13.00.

Vitalhub Stock Up 2.3%

Shares of VHI stock traded up C$0.20 during mid-day trading on Friday, reaching C$8.81. 247,513 shares of the stock traded hands, compared to its average volume of 334,529. The company has a market cap of C$558.02 million, a price-to-earnings ratio of 73.42, a price-to-earnings-growth ratio of 1.18 and a beta of 0.91. The stock’s fifty day simple moving average is C$7.33 and its two-hundred day simple moving average is C$7.50. Vitalhub has a 1-year low of C$6.46 and a 1-year high of C$12.72.

Vitalhub (TSE:VHI) last released its quarterly earnings data on Thursday, August 6th. The company reported C$0.03 earnings per share (EPS) for the quarter. The company had revenue of C$31.74 million during the quarter. Vitalhub had a return on equity of 2.79% and a net margin of 5.89%. On average, equities research analysts anticipate that Vitalhub will post 0.2296467 EPS for the current fiscal year.

About Vitalhub

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.